AstraZeneca sues Mylan after Faslodex generic bid

08-08-2016

AstraZeneca sues Mylan after Faslodex generic bid

garajstock / Shutterstock.com

AstraZeneca has sued Mylan for allegedly infringing its patents covering the drug Faslodex (fulvestrant).


AstraZeneca, Mylan, patent, Faslodex, fulvestrant, ANDA, FDA

More on this story

AstraZeneca prevails in inhaler dispute
09-03-2021

LSIPR